Oxbridge Re Reports Update on Business and Second Quarter 2024 Results
Rhea-AI Summary
Oxbridge Re Holdings (NASDAQ: OXBR) reported its Q2 2024 results, highlighting stable performance with no losses incurred. The company completed a $2.8 million private placement of tokenized securities through its subsidiary, SurancePlus Inc. Key financial metrics include:
- Q2 2024 net loss: $821,000 or $(0.14) per share
- H1 2024 net loss: $1.73 million or $(0.29) per share
- Q2 2024 net premiums earned: $564,000
- H1 2024 net premiums earned: $1.1 million
- Cash and equivalents as of June 30, 2024: $3.98 million
The company's focus on tokenized Real-World Assets (RWAs) and strategic partnership with Zoniqx position it for potential growth in the blockchain-based reinsurance sector.
Positive
- Completion of $2.8 million private placement in tokenized securities
- Strategic partnership with Zoniqx, which has issued over $4 billion in assets on-chain
- No losses incurred in Q2 2024
- Increase in net premiums earned to $564,000 in Q2 2024 from $183,000 in Q2 2023
- Strong balance sheet with no debt
Negative
- Q2 2024 net loss of $821,000 compared to net loss of $85,000 in Q2 2023
- H1 2024 net loss of $1.73 million compared to net profit of $57,000 in H1 2023
- Increase in unrealized losses on other investment and equity securities
- Higher policy and acquisition costs compared to the prior year
News Market Reaction 1 Alert
On the day this news was published, OXBR declined 4.43%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
GRAND CAYMAN, Cayman Islands, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), together with its subsidiaries which is engaged in the business of tokenized Real-World Assets (“RWAs”) initially in the form of tokenized reinsurance securities, and reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States, reported its results for the three and six months ended June 30, 2024.
“Our stable performance persisted into the second quarter of 2024, with no losses incurred,” stated Jay Madhu, Chairman and Chief Executive Officer of Oxbridge Re Holdings.
“Following Delta CatRe’s targeted
We also recently announced a strategic partnership with Zoniqx, which has issued over
“Looking ahead, with a strong balance sheet, no debt, and a well-diversified business from our recent transactions, we remain highly confident in our future ability to deliver shareholder value,” concluded Jay Madhu.
Financial Performance
For the three months ended June 30, 2024, the Company generated a net loss of
Net premiums earned for the three months ended June 30, 2024 were
There were no losses incurred for the three and six months ended June 30, 2024 or 2023.
Total expenses were
At June 30, 2024, cash and cash equivalents, and restricted cash and cash equivalents were
Financial Ratios
Loss Ratio. The loss ratio, which measures underwriting profitability, is the ratio of losses and loss adjustment expenses incurred to net premiums earned. The loss ratio was
Acquisition Cost Ratio. The acquisition cost ratio, which measures operational efficiency and compares policy acquisition costs with net premiums earned, increased marginally to
Expense Ratio. The expense ratio, which measures operating performance, compares policy acquisition costs and general and administrative expenses with net premiums earned. The expense ratio decreased to
Combined ratio. The combined ratio, which is used to measure underwriting performance, is the sum of the loss ratio and the expense ratio. The combined ratio decreased to
SurancePlus Offering
On July 11, 2024, SurancePlus Inc. (“SurancePlus”), an indirect wholly owned subsidiary of Oxbridge Re Holdings Limited (“Oxbridge”), completed its private placement (the “Private Placement”) of Participation Shares (the “Securities”) represented by digital tokens issued under a 3-year Participation Share Investment Contract (the “PSIC”). On July 11, 2024, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 287,705 of the Participation Shares represented by the digital tokens, EpsilonCat Re at a purchase price of
Conference Call
Management will host a conference call later today to discuss these financial results, followed by a question and-answer session. President and Chief Executive Officer Jay Madhu and Chief Financial Officer Wrendon Timothy will host the call starting at 4:30 p.m. Eastern time. The live presentation can be accessed by dialing the number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.oxbridgere.com.
Date: August 8, 2024
Time: 4.30 p.m. Eastern time
Toll-free number: 877 524-8416
International number: +1 412 902-1028
Passcode (required): 13746518
Please call the conference telephone number 10 minutes before the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact InComm Conferencing at 201 493-6280 or 877 804-2066
A replay of the call will be available by telephone after 4:30 p.m. Eastern time on the same day of the call and via the Investor Information section of Oxbridge’s website at www.oxbridgere.com until August 22nd, 2024.
Toll-free replay number: 877-660-6853
International replay number: +1-201-612-7415
Conference ID: 13746518
About Oxbridge Re Holdings Limited
Oxbridge Re Holdings Limited (NASDAQ: OXBR, OXBRW) (“Oxbridge Re”) is headquartered in the Cayman Islands. The company offers tokenized Real-World Assets (“RWAs”) as tokenized reinsurance securities and reinsurance business solutions to property and casualty insurers, through its wholly owned subsidiaries SurancePlus Inc, Oxbridge Re NS, and Oxbridge Reinsurance Limited.
Insurance businesses in the Gulf Coast region of the United States purchase property and casualty reinsurance through our licensed reinsurers Oxbridge Reinsurance Limited and Oxbridge Re NS.
Our new Web3-focused subsidiary, SurancePlus Inc. (“SurancePlus”), has developed the first “on-chain” reinsurance RWA of its kind to be sponsored by a subsidiary of a publicly traded company. By digitizing interests in reinsurance contracts as on-chain RWAs, SurancePlus has democratized the availability of reinsurance as an alternative investment to both U.S. and non-U.S. investors.
Forward-Looking Statements
This press release may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project” and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on 26th March 2024. The occurrence of any of these risks and uncertainties could have a material adverse effect on the Company’s business, financial condition and results of operations. Any forward-looking statements made in this press release speak only as of the date of this press release and, except as required by law, the Company undertakes no obligation to update any forward-looking statement contained in this press release, even if the Company’s expectations or any related events, conditions or circumstances change.
Company Contact:
Oxbridge Re Holdings Limited
Jay Madhu, CEO
345-749-7570
jmadhu@oxbridgere.com
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Balance Sheets
(expressed in thousands of U.S. Dollars, except per share and share amounts)
| At June 30, 2024 | At December 31, 2023 | |||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Investments: | ||||||||
| Equity securities, at fair value (cost: | $ | 213 | 680 | |||||
| Cash and cash equivalents | 3,594 | 495 | ||||||
| Restricted cash and cash equivalents | 391 | 3,250 | ||||||
| Premiums receivable | 2,118 | 977 | ||||||
| Other Investments | 965 | 2,478 | ||||||
| Loan Receivable | - | 100 | ||||||
| Due from Related Party | 63 | 63 | ||||||
| Deferred policy acquisition costs | 240 | 101 | ||||||
| Operating lease right-of-use assets | 124 | 9 | ||||||
| Prepayment and other assets | 113 | 96 | ||||||
| Property and equipment, net | 2 | 4 | ||||||
| Total assets | $ | 7,823 | 8,253 | |||||
| Liabilities and Shareholders’ Equity | ||||||||
| Notes payable to noteholders | 118 | 118 | ||||||
| Notes payable to Epsilon DeltaCat Re Tokenholders | 1,239 | 1,523 | ||||||
| Unearned Premium Reserve | 2,181 | 915 | ||||||
| Operating lease liabilities | 124 | 9 | ||||||
| Accounts payable and other liabilities | 374 | 356 | ||||||
| Total liabilities | 4,036 | 2,921 | ||||||
| Shareholders’ equity: | ||||||||
| Ordinary share capital, (par value | 6 | 6 | ||||||
| Additional paid-in capital | 32,921 | 32,740 | ||||||
| Accumulated Deficit | (29,140 | ) | (27,414 | ) | ||||
| Total shareholders’ equity | 3,787 | 5,332 | ||||||
| Total liabilities and shareholders’ equity | $ | 7,823 | 8,253 | |||||
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited)
(expressed in thousands of U.S. Dollars, except per share amounts)
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Revenue | ||||||||||||||||
| Assumed premiums | $ | 2,379 | 2,196 | 2,379 | 2,196 | |||||||||||
| Change in unearned premiums reserve | (1,815 | ) | (2,013 | ) | (1,266 | ) | (2,013 | ) | ||||||||
| Net premiums earned | 564 | 183 | 1,113 | 183 | ||||||||||||
| SurancePlus management fee income | 312 | 300 | 312 | 300 | ||||||||||||
| Net investment and other income | 65 | 79 | 126 | 168 | ||||||||||||
| Interest and gain on redemption of loan receivable | - | - | 41 | - | ||||||||||||
| Unrealized (loss) gain on other investments | (825 | ) | 124 | (1,513 | ) | 505 | ||||||||||
| Change in fair value of equity securities | (72 | ) | 5 | (160 | ) | 81 | ||||||||||
| Total revenue | 44 | 691 | (81 | ) | 1,237 | |||||||||||
| Expenses | ||||||||||||||||
| Policy acquisition costs and underwriting expenses | 62 | 20 | 122 | 20 | ||||||||||||
| General and administrative expenses | 566 | 677 | 1,054 | 1,081 | ||||||||||||
| Total expenses | 628 | 697 | 1,176 | 1,101 | ||||||||||||
| Income (Loss) before income attributable to noteholders and tokenholders | (584 | ) | (6 | ) | (1,257 | ) | 136 | |||||||||
| Income attributable to noteholders and tokenholders | (237 | ) | (79 | ) | (469 | ) | (79 | ) | ||||||||
| Net (loss) income | $ | (821 | ) | (85 | ) | (1,726 | ) | 57 | ||||||||
| (Loss) earnings per share | ||||||||||||||||
| Basic and Diluted | $ | (0.14 | ) | (0.01 | ) | (0.29 | ) | 0.01 | ||||||||
| Weighted-average shares outstanding | ||||||||||||||||
| Basic and Diluted | 6,010,561 | 5,870,234 | 6,007,868 | 5,863,973 | ||||||||||||
| Performance ratios to net premiums earned: | ||||||||||||||||
| Loss ratio | 0.0 | % | 0.0 | % | 0.0 | % | 0.0 | % | ||||||||
| Acquisition cost ratio | 11.0 | % | 10.9 | % | 11.0 | % | 10.9 | % | ||||||||
| Expense ratio | 111.3 | % | 380.9 | % | 105.7 | % | 601.6 | % | ||||||||
| Combined ratio | 111.3 | % | 380.9 | % | 105.7 | % | 601.6 | % | ||||||||
Attachment
FAQ
What was Oxbridge Re's (OXBR) net loss for Q2 2024?
How much did Oxbridge Re (OXBR) raise in its recent private placement?
What was Oxbridge Re's (OXBR) net premiums earned for Q2 2024?
Did Oxbridge Re (OXBR) incur any losses in Q2 2024?
What was Oxbridge Re's (OXBR) cash position as of June 30, 2024?
